C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2006
11/08/2006	EP1719765A1 Novel sulfone amide derivative
11/08/2006	EP1719761A1 Novel heterocyclic compound
11/08/2006	EP1719511A2 N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide, a pharmaceutical composition comprising the same and use thereof
11/08/2006	EP1718648A1 Tricyclic imidazopyridines and intermediates for the synthesis thereof
11/08/2006	EP1718647A1 Prodrugs of substituted amino heterobicycles which modulate the function of the vanilloid-1 receptor (vr1)
11/08/2006	EP1718646A1 1,2,4-triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders
11/08/2006	EP1718645A1 2-(pyridin-3-ylamino)-pyrido 2,3-d pyrimidin-7-ones
11/08/2006	EP1718635A1 Piperidinyl targeting compounds that selectively bind integrins
11/08/2006	EP1718300A2 Conformationally constrained smac mimetics and the uses thereof
11/08/2006	EP1718299A1 Heterocyclic gaba-a subtype selective receptor modulators
11/08/2006	EP1718152A2 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
11/08/2006	EP1587810B1 Novel substituted 1,4\|benzodioxino 2,3-e\|isoindole derivatives, method for preparing same and pharmaceutical compositions containing same
11/08/2006	EP1539742B1 Indole derivatives useful as histamine h3 antagonists
11/08/2006	EP1419155B1 Piperidine derivatives as antibacterial agents
11/08/2006	CN1860118A Compounds and compositions as protein kinase inhibitors
11/08/2006	CN1860117A Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
11/08/2006	CN1860113A Nicotinamide derivatives useful as PDE4 inhibitors
11/08/2006	CN1858050A 8-iodo-imidazo[1,2-alpha] pyridine-3-acetamide compound and preparing method
11/08/2006	CN1283640C Ramification in albocarbon category and application in anoxia system
11/08/2006	CN1283639C Pirenzepine organic acid salt and eye drops for treating myopia
11/07/2006	US7132547 Preventives/remedies for urinary disturbance
11/07/2006	US7132536 Endothelial nitric oxide synthase expression stimulants; cardiovascular disorders
11/07/2006	US7132440 such as 2-[4-(2-Phenyl-[1,3]dioxolan-2-yl)-phenyl]-1H-benzoimidazole-5-carboxylic acid amide; for treatment of cancer
11/07/2006	US7132439 Bis-benzimidazoles and related compounds as potassium channel modulators
11/07/2006	US7132438 Benzimidazole derivatives
11/07/2006	US7132435 Syn-1H-indazole-3-carboxylic acid (4-{[2-(2,3-dihydro-benzo[b]thiophen-6-yloxy)-5-fluoro-pyridine-3-carbonyl]amino}-cyclohexyl)-amide; useful as cyclic nucleotide phosphodiesterase-4 ( PDE-4 ) inhibitor
11/07/2006	US7132429 Sulfonamido ether substituted imidazoquinolines
11/07/2006	US7132428 5-pyridin-2-yl-3-trifluoromethyl-1H-pyrazolo[4,3-c]isoquionoline; useful for treating osteoarthritis, rheumatoid arthritis and asthma
11/07/2006	US7132426 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
11/07/2006	CA2192824C Pyridone-carboxylic acid derivatives, processes for the preparation thereof and anti-tumor agents containing the pyridone-carboxylic acid derivatives
11/07/2006	CA2146961C Heterobicyclic sulfonamide and sulfonic ester derivatives
11/07/2006	CA2131680C Process for preparing imidazopyridine derivatives
11/02/2006	WO2006116764A1 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
11/02/2006	WO2006114706A1 Triazole derivatives as vasopressin antagonists
11/02/2006	WO2006114676A2 A process for the preparation of rupatadine
11/02/2006	WO2006114606A1 Fused thiazole derivatives as kinase inhibitors
11/02/2006	WO2006114520A2 Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
11/02/2006	WO2006114384A1 Preparation of aseptic 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4h-pyridio[1,2-a]pyrimidin-4-one palmitate ester
11/02/2006	WO2006114313A1 Pyrazole compounds as prostaglandin receptors ligands
11/02/2006	WO2006114274A1 Oxazole and thiazole compounds and their use in the treatment of pge2 mediated disorders
11/02/2006	WO2006114272A1 FURAN COMPOUNDS USEFUL AS EPl RECEPTOR ANTAGONISTS
11/02/2006	WO2006114263A1 Imidazo [1, 2-a] pyridine derivatives useful as peptide deformylase (pdf) inhibitors
11/02/2006	WO2006114261A1 Imidazo(1,2-a)pyridine derivatives useful as peptide deformylase (pdf) inhibitors
11/02/2006	WO2006114180A1 Novel aza- heterocycles serving as kinase inhibitors
11/02/2006	WO2006092032A3 PHARMACEUTICAL COMPOSITIONS CONTAINING 1-METHYL-3,6,7,8-TETRAHYDROPIRAZOLO[3,4-b]PIRROLO[4,3-d]PYRIDINE-6,8-DIONE DERIVATIVES, USE, AND PROCESS FOR PREPARING THEM
11/02/2006	WO2006061380A3 SUBSTITUTED IMIDAZO[4,5-b]PYRIDINES AS INHIBITORS OF GASTRIC ACID SECRETION
11/02/2006	WO2006059149A8 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
11/02/2006	US20060247289 Certain chemical entities, compositions, and methods
11/02/2006	US20060247275 Treating hyperproliferative disorders such as gastrointestinal cancer, breast cancer, head cancer, or neck cancer; N-(4-trifluoromethoxyphenyl) 3-[(quinolin-4-ylmethyl)amino]thiophene-2-carboxamide
11/02/2006	US20060247270 3-Substituted-2(Arylalkyl)-1-Azabicycloalkanes and Methods of Use Thereof
11/02/2006	US20060247266 Nitrogen-containing tricyclic compounds
11/02/2006	US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006	US20060247228 Phenylazole compounds production process and antioxidants
11/02/2006	US20060247217 Tricyclic protein kinase inhibitors
11/02/2006	US20060247212 Heterocyclic compounds having inhibitory activity against HIV integrase
11/02/2006	US20060247211 Cytotoxic indeno and isoindoloisoquinolones
11/02/2006	US20060246023 Solvent-free process for the preparation of diketopyrrolopyrrole derivatives
11/02/2006	US20060246012 Delivery of physiologically active compounds through an inhalation route
11/02/2006	US20060246011 Delivery of diphenhydramine through an inhalation route
11/02/2006	EP1717238A1 Fungicidal heterocyclic compounds
11/02/2006	EP1717230A1 Fused-ring 4-oxopyrimidine derivative
11/02/2006	EP1717220A2 Vanilloid receptor ligands and their use in treatments
11/02/2006	EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both
11/02/2006	EP1716151A1 Compositions useful as inhibitors of protein kinases
11/02/2006	EP1716150A2 Substituted heterocyclic compounds and methods of use
11/02/2006	EP1716148A2 Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof
11/02/2006	EP1716147A1 Diaza-spiropiperidine derivatives as inhibitors of glycine transporter 1 and glycine transporter 2
11/02/2006	EP1716146A1 Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof
11/02/2006	EP1716145A1 Dihydrotetrabenazines and pharmaceutical compositions containing them
11/02/2006	EP1716134A1 Amino heterocyclic modulators of chemokine receptor activity
11/02/2006	EP1716125A1 Tetrazole compounds and their use as metabotropic glutamate receptor antagonits
11/02/2006	EP1715862A1 Kinase inhibitors
11/02/2006	EP1578723A4 Process for the preparation of oxazolidinones and method of use thereof
11/02/2006	EP1202976B1 Pyrazinones, compositions containing such compounds
11/02/2006	EP1192133B1 N-cyclopentyl modulators of chemokine receptor activity
11/02/2006	EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006	EP0885883B1 Fused heterocyclic compounds and pharmaceutical applications thereof
11/02/2006	EP0823908B1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
11/02/2006	DE102005018025A1 New heterocyclic compounds which are cytokine interleukin-8 inhibitors useful for treating e.g., chronic obstructive lung disease, bronchitis, rheumatoid arthritis, psoriasis, gastrointestinal disease and Crohn's disease
11/02/2006	CA2607426A1 Fused thiazole derivatives as kinase inhibitors
11/02/2006	CA2606251A1 Imidazo(1,2-a)pyridine derivatives useful as peptide deformylase (pdf) inhibitors
11/02/2006	CA2605925A1 Imidazo [1, 2-a] pyridine derivatives useful as peptide deformylase (pdf) inhibitors
11/02/2006	CA2605744A1 Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
11/01/2006	CN1856495A Imidazopyridine-derivatives as inducible NO-synthase inhibitors
11/01/2006	CN1856494A Imidazopyridine-derivatives as inducible NO-synthase inhibitors
11/01/2006	CN1856493A Aminopyridine-derivatives as inductible NO-synthase inhibitors
11/01/2006	CN1856492A Imidazo(4,5-B)pyridine-derivatives as inducible NO-synthase inhibitors
11/01/2006	CN1856491A Imidazopyridine-derivatives as inductible NO-synthase inhibitors
11/01/2006	CN1856490A Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
11/01/2006	CN1856476A Isoquinolinone potassium channel inhibitors
11/01/2006	CN1856310A 喹唑啉钾通道抑制剂 Quinazoline potassium channel inhibitors
11/01/2006	CN1856309A Hexa- and octahydro-pyrido[1,2-a] pyrazine derivatives with NK1 antagonistic activity
11/01/2006	CN1856304A Derivatives of N-(1H-indazolyl)- and N-(1H-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (VR1) for the treatment of pain
11/01/2006	CN1854143A Production of catharanthine compound and its medicinal salt
11/01/2006	CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/2006
10/31/2006	US7129356 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/31/2006	US7129355 Process for preparing kifunensine intermediate and kifunensine therefrom
10/31/2006	US7129264 anticoagulants; antiinflammatory agents; cardiovascular disorders
10/31/2006	US7129262 Effective to reduce the viability and/or to sensitize the cancer to an anti-cancer agent.
10/31/2006	US7129253 Compounds

1 ... 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 ... 646